Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21965503 | 0.92 | KMT2A (0.38) | MEN1KMT2AATMKDM4EALDH1A1 | |
| SCHEMBL18542842 | 0.92 | PTGER4 (0.32) | MEN1KMT2AATMPTGER4KDM4E | |
| SCHEMBL8815486 | 0.92 | ALDH1A1 (0.37) | MEN1KMT2AATMPTGER4KDM4E | |
| SCHEMBL15138846 | 0.88 | PTGER4 (0.34) | ATMPTGER4KDM4EMAPTL3MBTL1 | |
| SCHEMBL17246753 | 0.87 | KDM4E (0.35) | ATMPTGER4KDM4EL3MBTL1 | |
| SCHEMBL21965518 | 0.87 | TNKS (0.32) | PTGER4MAPT | |
| SCHEMBL21965526 | 0.87 | TNKS (0.32) | PTGER4MAPT | |
| SCHEMBL15582481 | 0.86 | KDM4E (0.33) | ATMPTGER4KDM4EALDH1A1MAPT | |
| SCHEMBL16785810 | 0.86 | ALOX5 (0.40) | ATMPTGER4KDM4EALDH1A1MAPT | |
| SCHEMBL8815497 | 0.86 | ATM (0.40) | MEN1KMT2AATMPTGER4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11765966-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-20220359836-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-10 | — | — | US | disclosed |
| US-20210343950-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210343950-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | AOX1, OCIAD1, OCIAD2 | MEN1 4654/4885KMT2A 1952/4885ATM 4078/4885 |
| US-20220359836-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, EPCAM, EPM2A | MEN1 1877/4885KMT2A 3949/4885ATM 3147/4885 |
| US-11765966-B2 | Organic electroluminescent materials and devices | L1CAM, EPCAM, EPM2A | MEN1 1877/4885KMT2A 3949/4885ATM 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.